Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 04:11 pm EST
Ampio Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 1.23 million compared to USD 6.41 million a year ago. Basic loss per share from continuing operations was USD 1.53 compared to USD 8.51 a year ago. Diluted loss per share from continuing operations was USD 1.53 compared to USD 10.06 a year ago.
For the nine months, net loss was USD 6.58 million compared to USD 14.12 million a year ago. Basic loss per share from continuing operations was USD 8.18 compared to USD 18.73 a year ago. Diluted loss per share from continuing operations was USD 8.18 compared to USD 25.88 a year ago.